Elie Dolgin, PHD, Science Journalist

Svetlana Mojsov: Unsung drug developer

Elie Dolgin • December 13, 2023

How a biochemist finally gained recognition for her part in developing multibillion-dollar weight-loss drugs.

A new class of weight-loss drugs has swept into clinics and made medicines such as Ozempic and Wegovy household names. They have generated billions of dollars in profit for the pharmaceutical industry and brought scientific acclaim for the researchers credited with discovering the hormone behind them: an appetite suppressant called glucagon-like peptide-1 (GLP-1).


But there is one early pioneer who has not received due acknowledgement: Svetlana Mojsov.


A biochemist now at The Rockefeller University in New York City, Mojsov had a pivotal role in identifying and characterizing the active form of GLP-1. Yet her efforts went unrecognized in many accounts of the hormone’s discovery, and she has not shared the scientific prizes bestowed for that feat.


This year, Mojsov fought the entrenched narratives — and began to win wider recognition for her contributions to the field. “All I’m trying to do is put the scientific record straight,” she says.


Continue reading at Nature.

Mouse brain tissue imaged using expansion microscopy.
By Elie Dolgin January 13, 2025
How a tissue-swelling method brought super-resolution imaging to the masses.
Cartoon of cars and a bicycle moving through a tunnel inside a cell
By Elie Dolgin November 27, 2024
In response to cellular stress, proteins become ensnared in chemical traffic jams, creating a kind of widespread sluggishness scientists call “proteolethargy.”
Share by: